© 2015-2020 AIBIOS Co., Ltd.

INVESTORS

Global Series A fundraising will open in 2020 Q3 to complete Phase 1 clinical studies in Japan and the US.  Please contact us if your investment strategy is focused on IND enabling and early clinical phase development.